SCHEMBL1306823

SCHEMBL1306823

Cc1cc(C=C(COc2cccc3ccccc23)C(=O)NC(C)C2C=CCCC2)ccc1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TRPM4 Q8TD43 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ POLB P06746 2/20 0.35
▸ G6PD P11413 1/20 0.35
▸ P2RX3 P56373 2/20 0.35
▸ CASP3 P42574 5/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CASP8 Q14790 3/20 0.34
▸ CASP6 P55212 2/20 0.34
▸ DAPK1 P53355 1/20 0.34
▸ PIM3 Q86V86 1/20 0.34
▸ CASP1 P29466 3/20 0.34
▸ CASP7 P55210 2/20 0.33
▸ BCL2L1 Q07817 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306707 0.90 P2RX3 (0.40) ALDH1A1POLBP2RX3CASP3MEN1
SCHEMBL1305161 0.85 P2RX3 (0.46) ALDH1A1P2RX3CASP3MEN1KMT2A
SCHEMBL1306160 0.80 KMT2A (0.45) TRPM4ALDH1A1POLBG6PDP2RX3
SCHEMBL1306695 0.80 TRPM4 (0.42) TRPM4ALDH1A1POLBG6PDCASP3
SCHEMBL1306822 0.80 TSHR (0.38) TRPM4ALDH1A1POLBG6PDP2RX3
SCHEMBL1307999 0.79 P2RX3 (0.62) ALDH1A1P2RX3CASP3MEN1KMT2A
SCHEMBL1305884 0.79 ALDH1A1 (0.41) ALDH1A1CASP3MEN1KMT2AKDM4E
SCHEMBL1306568 0.78 P2RX3 (0.41) TRPM4ALDH1A1POLBG6PDP2RX3
SCHEMBL1306170 0.77 ALDH1A1 (0.48) ALDH1A1POLBKDM4EHPGDMAPT
SCHEMBL1305454 0.77 P2RX3 (0.42) TRPM4ALDH1A1POLBG6PDP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
Send feedback